SARS-CoV-2 Viral Variants-Tackling a Moving Target

JAMA. 2021 Apr 6;325(13):1261-1262. doi: 10.1001/jama.2021.2088.

Authors

John R Mascola¹, Barney S Graham¹, Anthony S Fauci²

Affiliations

¹ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
² Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

PMID: 33571363
DOI: 10.1001/jama.2021.2088

No abstract available

Publication types

Editorial
Comment

MeSH terms

COVID-19*
California
Humans
SARS-CoV-2*
Spike Glycoprotein, Coronavirus

Substances

Spike Glycoprotein, Coronavirus